Aveanna Healthcare (AVAH) Expected to Release Quarterly Earnings on Thursday

Aveanna Healthcare (NASDAQ:AVAH) is expected to be releasing its Q2 2026 results before the market opens on Thursday, August 13th. Analysts expect the company to post earnings of $0.1683 per share and revenue of $638.6090 million for the quarter. Investors may visit the the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Thursday, August 13, 2026 at 10:00 AM ET.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings results on Thursday, May 14th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.05. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The business had revenue of $647.91 million for the quarter, compared to analyst estimates of $613.22 million. Aveanna Healthcare’s quarterly revenue was up 15.9% compared to the same quarter last year. On average, analysts expect Aveanna Healthcare to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Aveanna Healthcare Stock Down 0.3%

Shares of Aveanna Healthcare stock opened at $9.46 on Tuesday. The business has a fifty day simple moving average of $8.67 and a 200 day simple moving average of $7.71. The stock has a market cap of $2.06 billion, a PE ratio of 8.02, a price-to-earnings-growth ratio of 0.94 and a beta of 1.90. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 5.35. Aveanna Healthcare has a 12 month low of $5.93 and a 12 month high of $10.32.

Analysts Set New Price Targets

A number of brokerages have issued reports on AVAH. Barclays raised their target price on Aveanna Healthcare from $9.00 to $9.50 and gave the stock an “overweight” rating in a report on Thursday, July 9th. Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Thursday, July 2nd. Truist Financial upped their target price on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th. Royal Bank Of Canada upgraded shares of Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 target price on the stock in a report on Wednesday, June 3rd. Finally, Stephens raised shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $10.00 to $11.00 in a research report on Friday, May 15th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $10.78.

Insider Activity at Aveanna Healthcare

In other Aveanna Healthcare news, insider Patrick A. Cunningham sold 125,000 shares of Aveanna Healthcare stock in a transaction dated Wednesday, May 20th. The stock was sold at an average price of $7.59, for a total value of $948,750.00. Following the sale, the insider owned 212,755 shares of the company’s stock, valued at $1,614,810.45. This trade represents a 37.01% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, major shareholder J.H. Whitney Equity Partners V sold 2,419,035 shares of the business’s stock in a transaction dated Tuesday, June 30th. The shares were sold at an average price of $8.01, for a total value of $19,376,470.35. Following the completion of the sale, the insider owned 10,112,123 shares in the company, valued at approximately $80,998,105.23. This trade represents a 19.30% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 31,305,664 shares of company stock valued at $215,555,910. 5.30% of the stock is owned by insiders.

Institutional Investors Weigh In On Aveanna Healthcare

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Quantbot Technologies LP acquired a new position in Aveanna Healthcare during the 2nd quarter worth approximately $43,000. Oxford Asset Management LLP acquired a new stake in shares of Aveanna Healthcare in the second quarter valued at approximately $64,000. Bayesian Capital Management LP bought a new stake in shares of Aveanna Healthcare in the second quarter worth $85,000. Jain Global LLC bought a new stake in shares of Aveanna Healthcare in the fourth quarter worth $102,000. Finally, Invesco Ltd. boosted its holdings in Aveanna Healthcare by 31.1% during the second quarter. Invesco Ltd. now owns 20,006 shares of the company’s stock worth $105,000 after purchasing an additional 4,742 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.